コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 an acute myocardial infarction or undergoing cardiovascular surgery.
2 ndent risk factor for adverse outcomes after cardiovascular surgery.
3 transfusion strategy for patients undergoing cardiovascular surgery.
4 of neurologic injury, traumatic injury, and cardiovascular surgery.
5 nal fluid (CSF) of patients undergoing major cardiovascular surgery.
6 ve heart failure, myocardial infarction, and cardiovascular surgery.
7 Two patients had prior noncoarctation cardiovascular surgery.
8 sed extensively as a hemostatic agent during cardiovascular surgery.
9 prevention of atrial fibrillation following cardiovascular surgery.
10 on and the length of hospital stay following cardiovascular surgery.
11 istered to prevent thrombus formation during cardiovascular surgery.
12 with increased morbidity and mortality after cardiovascular surgery.
13 nt of a generalized inflammatory reaction to cardiovascular surgery.
14 with severe heart or lung failure following cardiovascular surgery.
15 oreal membrane oxygenation therapy following cardiovascular surgery.
21 oreal membrane oxygenation support following cardiovascular surgery and aimed to improve established
23 ict advanced AKI or hospital mortality after cardiovascular surgery and improve in SOFA outcome asses
24 rom 19.1% in neurosurgery, 18.9% in thoracic-cardiovascular surgery, and 15.3% in general surgery to
25 commonly used after cardiac catheterization, cardiovascular surgery, and exposure to intravenous cont
26 cant morbidity and mortality associated with cardiovascular surgery, and is the end result of multipl
27 of acute kidney injury (AKI), with AKI after cardiovascular surgeries being a prototype of prognosis
28 ischemic conditioning in patients undergoing cardiovascular surgery, both with neutral results in ter
31 compared with those with type II, underwent cardiovascular surgery earlier (mean age, 16.9 years vs.
33 h-volume and low-volume hospitals performing cardiovascular surgery have similar complication rates b
34 etic grafts and patches are commonly used in cardiovascular surgery, however neointimal hyperplasia r
35 native anticoagulation is available, but for cardiovascular surgery, if the operation cannot be delay
36 rgical coronary revascularization, and other cardiovascular surgery in many, but not in all, studies.
37 orthopedic surgery, neurosurgery, radiology, cardiovascular surgery, obstetrics and gynecology, and g
39 ostatic therapy in clinical settings such as cardiovascular surgery, postpartum hemorrhage, and traum
41 ibrillation (AF) is a common complication of cardiovascular surgery that is associated with a signifi
42 , important to the history of cardiology and cardiovascular surgery, that were published in volume 1
43 ied high-risk subgroups (patients undergoing cardiovascular surgery, those admitted to intensive care
44 ase, recent myocardial infarction, and prior cardiovascular surgery to be associated with need for po
45 ve surgery, ascending aortic surgery, or any cardiovascular surgery was required in 24+/-4%, 5+/-2%,
46 vels were elevated in children who completed cardiovascular surgery with an open chest compared with
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。